Mocetinostat
Drug timelines are a Plus or Pro feature.
9 regulatory and trial events tracked for Mocetinostat, covering 2017-09-01 to 2025-08-06. Get the full timeline:
Most recent: Clinical Trial Update: Pembrolizumab (Immunotherapy Drug) in Combination With Guadecitabine and Mocetinostat (Epigenetic Drugs) for Patients With Advanced Lung Cancer. [Phase 1]